|Minimum Order Quantity||1 Box|
|Packaging Size||50 Capsule|
|Treatment||other medicines to help prevent organ rejection in people who have had a kidney, liver, or heart tr|
PROGRAF (Tacrolimus 0.5 Mg) is a prescription medicine used with other medicines to help prevent organ rejection in people who have had a kidney, liver, or heart transplant.
PROGRAF capsules and PROGRAF Granules are types of tacrolimus immediate-release drugs and they are not the same as tacrolimus extended-release tablets or tacrolimus extended-release capsules. Your healthcare provider should decide what medicine is right for you.
IMPORTANT SAFETY INFORMATION
What is the most important information I should know about PROGRAF?
PROGRAF can cause serious side effects, including:
Increased risk of cancer. People who take PROGRAF have an increased risk of getting some kinds of cancer, including skin and lymph gland cancer (lymphoma).
Increased risk of infection. PROGRAF is a medicine that affects your immune system. PROGRAF can lower the ability of your immune system to fight infections. Serious infections can happen in people receiving PROGRAF that can cause death. Call your healthcare provider right away if you have any symptoms of an infection, including:
Fevermuscle achessweats or chillswarm, red, or painful areas on your skincough or flu-like symptoms
Do not take PROGRAF if you are allergic to tacrolimus or any of the ingredients in PROGRAF.
What should I tell my healthcare provider before taking PROGRAF?
Before you take PROGRAF, tell your healthcare provider about all of your medical conditions, including if you:
plan to receive any live vaccines (people taking PROGRAF should not receive live vaccines)
have or have had liver, kidney or heart problems
are pregnant or plan to become pregnant. PROGRAF can harm your unborn baby.
If you are able to become pregnant, you should use effective birth control before and during treatment with PROGRAF. Talk to your healthcare provider before starting treatment with PROGRAF about birth control methods that may be right for you.
Males who have female partners who are able to become pregnant should also use effective birth control before and during treatment with PROGRAF. Talk to your healthcare provider before starting treatment with PROGRAF about birth control methods that may be right for you.
are breastfeeding or plan to breastfeed. PROGRAF passes into your breast milk. You and your healthcare provider should decide if you will breastfeed while taking PROGRAF.
Tell your healthcare provider about all the medicines you take, and when you start a new medicine or stop taking a medicine, including prescription and over-the-counter medicines; vitamins; natural, herbal or nutritional supplements. Especially tell your healthcare provider if you take:
cyclosporine (GENGRAF, NEORAL, and SANDIMMUNE)
medicines called aminoglycosides that are used to treat bacterial infections
ganciclovir (CYTOVENE IV, VALCYTE)
amphotericin B (ABELCET, AMBISOME)
antiviral medicines called nucleoside reverse transcriptase inhibitors
antiviral medicines called protease inhibitors
water pill (diuretic)
medicine to treat high blood pressure
ritonavir (KALETRA, NORVIR, TECHNIVIETM, VIEKIRA PAK, VIEKIRA XRTM)
itraconazole (ONMEL, SPORANOX)
clarithromycin (BIAXIN, BIAXIN XL, PREVPAC)
rifampin (RIFADIN, RIFAMATE, RIFATER, RIMACTANE)
amiodarone (NEXTERONE, PACERONE)
Ask your healthcare provider or pharmacist if you are not sure if you take any of the medicines listed above. PROGRAF may affect the way other medicines work, and other medicines may affect how PROGRAF works. Know the medicines you take.
- Production Capacity: NA
- Delivery Time: Immediate
- Packaging Details: Trademark shown are property of their respective owners and we do not lay any claim on them. Parallel trade if any is conducted under WTO¿¿¿s TRIPS agreement to which India is a Signatory. On this page we have made an ¿¿¿Honest Reference¿¿¿ of this product under the Trademark Act of India and applicable rules in the Territory of India. We do not claim ownership of displayed Trade mark.